Molecular Devices Enters Niche LCM, Sample Prep Markets with Acquisition of Arcturus Unit | GenomeWeb

Entering a new market, Molecular Devices has acquired the laser capture microdissection (LCM) business of Arcturus Biosicence for $10 million in cash.

The acquisition pushes Molecular Devices into the sample preparation products arena and puts the company in competition with other LCM tool providers, such as Leica Microsystems, Molecular Machines & Industries (MMI), and Carl Zeiss, which has an alliance for the technology with BCW Index firm Qiagen.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.